Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
carbidopa monohydrate, Quantity: 27 mg (Equivalent: carbidopa, Qty 25 mg); levodopa, Quantity: 250 mg
ORGANON PHARMA PTY LTD
Tablet, uncoated
Excipient Ingredients: indigo blue; maize starch; magnesium stearate; microcrystalline cellulose; pregelatinised maize starch
Oral
100
(S4) Prescription Only Medicine
SINEMET is indicated for the treatment of Parkinson's disease and syndrome. It is useful in relieving many of the symptoms of parkinsonism, particularly rigidity and bradykinesia. SINEMET frequently is helpful in the management of tremor, dysphagia, sialorrhoea and postural instability associated with Parkinson's disease and syndrome.
Visual Identification: Light dapple blue oval tablet with 654 and a score line on one side and plain on the other.; Container Type: Bottle; Container Material: HDPE; Container Life Time: 2 Years; Container Temperature: Store below 30 degrees Celsius; Container Closure: Child resistant closure
Registered
2019-11-15
SINEMET ® _Carbidopa-Levodopa_ CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some common questions about SINEMET. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you taking SINEMET against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH THE MEDICINE. You may need to read it again. WHAT SINEMET IS USED FOR SINEMET is used to treat some of the symptoms of Parkinson's disease. This is a disease of the nervous system that mainly affects body movement. The three main symptoms are shaking (tremor), muscle stiffness and slow and unsteady movement. People with Parkinson's disease often walk with a shuffle as they have difficulty in initiating movement. If untreated, Parkinson's disease can cause difficulty in performing normal daily activities. SINEMET is most helpful in improving slow movement and muscle stiffness. It is also frequently helpful in treating shaking, difficulty in swallowing and drooling. The symptoms of Parkinson's disease are caused by a lack of dopamine, a naturally occurring chemical produced by certain brain cells. Dopamine relays messages in the part of the brain that controls muscle movement. When too little dopamine is produced slowness of movement results. SINEMET contains two active ingredients, levodopa and carbidopa. Levodopa is a chemical closely related to dopamine which allows the body to make its own dopamine. Carbidopa makes sure that enough levodopa gets to the brain where it is needed. In many patients, SINEMET reduces some of the symptoms of Parkinson's disease. Your doctor may have prescribed SINEMET for another reason. Ask your doctor if you have any questions about why SINEMET has been prescribed for you. BEFORE YOU TAKE SINEMET _WHEN YOU MUST NOT TAKE IT_ DO NOT TAKE SINEMET IF: • YOU HAVE AN ALLERGY T Read the complete document
Page 1 of 12 AUSTRALIAN PRODUCT INFORMATION SINEMET ® (LEVODOPA AND CARBIDOPA) TABLET 1 NAME OF THE MEDICINE Levodopa and carbidopa 2 QUALITATIVE AND QUANTITATIVE COMPOSITION _Carbidopa _ Carbidopa, an inhibitor of aromatic amino acid decarboxylase, is a white, crystalline compound, slightly soluble in water. _Levodopa _ Levodopa, an aromatic amino acid, is a white, crystalline compound, slightly soluble in water. SINEMET 250/25 tablets contain levodopa 250 mg and carbidopa 25 mg and SINEMET 100/25 tablets contain levodopa 100 mg and carbidopa 25 mg. For the full list of excipients, see SECTION 6.1 LIST OF EXCIPIENTS. 3 PHARMACEUTICAL FORM SINEMET is supplied as tablets for oral administration. SINEMET 250/25: light dapple blue oval tablet with 654 and a score line on one side and plain on the other. SINEMET 100/25: yellow oval tablet with 650 and a score line on one side and plain on the other. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS SINEMET is indicated for the treatment of Parkinson's disease and syndrome. It is useful in relieving many of the symptoms of parkinsonism, particularly rigidity and bradykinesia. SINEMET frequently is helpful in the management of tremor, dysphagia, sialorrhoea and postural instability associated with Parkinson's disease and syndrome. 4.2 DOSE AND METHOD OF ADMINISTRATION The optimum daily dosage of SINEMET must be determined by careful titration in each patient. SINEMET tablets are available in a 1:4 ratio of carbidopa to levodopa (SINEMET 100/25) as well as a 1:10 ratio (SINEMET 250/25). Tablets of the two ratios may be given separately or combined as needed to provide the optimum dosage. The tablet score-line for SINEMET 100/25 is only to facilitate breaking for ease of swallowing and not to divide into equal doses. If subdivided, the tablet should be consumed as a whole dose. The tablet score-line for SINEMET 250/25 can be divided into equal doses. Page 2 of 12 GENERAL CONSIDERATIONS Dosage should be titrated to individual patient needs and this may require adjusting Read the complete document